CHRISTINE AREZZI: Open Payments
NPI 1942917075 · EAST STROUDSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 110 payments from 13 companies in 2025. Trend: 2023 $726 · 2024 $1,443 · 2025 $2,028
Food & beverage: $1,919Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $474 |
| ABBVIE INC. | 31 | $420 |
| Alkermes, Inc. | 13 | $270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $207 |
| Neurocrine BioSciences, Inc. | 5 | $146 |
| Janssen Pharmaceuticals, Inc | 6 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Bausch Health US, LLC | 4 | $67 |
| Lundbeck LLC | 3 | $56 |
Products named: VRAYLAR, AUSTEDO XR, ARISTADA, CAPLYTA, INGREZZA, INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
